Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
10,955 total articles
Baidu is trading near cycle lows after search revenue pressure, but the company’s AI Cloud and data-center exposure — backed by industry growth and recent partnership headlines — provide a clear catalyst for a mid-term swing trade. The setup offers asymmetric upside with a defined stop below the recent low.
Public Service Enterprise Group (PEG) looks like a pragmatic buy: stable regulated utility economics, a 3.4% yield backed by consecutive dividend increases, and optional upside from its 3,758 MW carbon-free nuclear fleet. Valuation is fair (P/E ~19, P/B ~2.17) and the balance sheet shows leverage that demands respect. This trade idea targets capita…
Figure Technology (FIGR) is accelerating consumer loan originations and integrating the Kiavi platform, which together support management's goal of 60%+ EBITDA margins. With Q1 net revenue of $167M, Consumer Loan Marketplace momentum (Q1 volume $2.9B, May monthly $1.402B) and a $7B lift from Kiavi, the stock looks actionable for a long trade. Entry…
Applied Digital (APLD) is transitioning from build phase to cash-generating AI landlord. Revenue is accelerating, HPC margins are exceptional, and a $36 billion contracted lease backlog provides long-term visibility. The trade: enter at $28.42, stop at $24.00, primary target $40.00 over a 180 trading day horizon, with a medium risk profile.
Amylyx (AMLX) is trading at a fresh 52-week high after a cluster of program updates and volume-driven momentum. With a market cap near $3.7B, an active float under 95M shares, heavy short interest and several 2026 clinical/regulatory catalysts ahead, the risk/reward favors a directional long for patient traders who control risk tightly. This piece …
Palantir's Q2 results and AI-driven commercial wins are real, but the stock's valuation and technical setup suggest the easiest gains have already occurred. This trade idea proposes a mid-term (45 trading days) short designed to capture a reversion toward the 20-day moving average while limiting blowup risk with a tight stop.
Dave Inc. combines a sticky user base with strong unit economics and sizable free cash flow. At $344.71 with a market cap near $4.38B, the stock still trades at a premium vs. sales but shows improving profitability and a balance-sheet cushion from a $175M convertible note. This trade targets continued enterprise multiple expansion while managing do…
Nano Labs is a Hangzhou-based fabless designer of high-throughput and vision computing chips that has signaled ambitions in AI data center infrastructure. The stock is a microcap ($44.6M market cap) trading near $1.92 with thin volume and elevated short interest at points this year. I view NA as a speculative swing trade: the upside is tied to exec…
Cummins is morphing from an engine supplier into the infrastructure-grade vendor for stranded power needs. With Power Systems showing high margins and a multi-year backlog, the stock looks actionable on a medium-term bounce. Trade idea: buy at $621.45, stop $560.00, target $740.00 (primary) — horizon ~45 trading days.
Nebius Group (NBIS) has sprinted into the AI infrastructure spotlight with outsized revenue growth, a $27B deal, and strategic capital from Nvidia. That combination gives the stock a legitimate runway toward $1,000 if growth and margins continue to accelerate. This is an actionable long trade for disciplined investors who can tolerate high volatili…
Palantir's Q2 cadence and guidance have pushed enterprise AI adoption into hyperdrive: revenue growth near 93% with U.S. commercial revenue up 149%. Valuation is rich, but cash generation, margin profile, and technical momentum make a disciplined long with a $170 entry and $220 target a high-conviction trade for the next 180 trading days.
Nucor benefits from a stronger tariff environment, targeted capacity expansion, and sustained infrastructure demand. We recommend a tactical long with a mid-term horizon, clear stop and target, and a contingency plan if underlying demand weakens.
Kinross Gold (KGC) is trading near $27.25 after an S&P upgrade to BBB and with a reported net cash position of $1.9B and total liquidity of $4.4B. Lobo-Marte and a pipeline of projects improve growth visibility; combine that with record free cash flow and steady shareholder returns and you have a constructive setup for a swing trade. Entry $27.25, …
Monopar has pushed ALXN1840 toward a regulatory inflection point. With an in-license pedigree, positive Phase 2 and Phase 3 signals, cash runway through late-2027, and a rolling NDA process underway, MNPR presents a favorable asymmetric risk-reward for a long position. This trade idea lays out an entry at $116, stop at $95, and a $150 target over a…
Kratos (KTOS) trades near $63 with strong defense market tailwinds and a stretched valuation that only makes sense if operating margins improve. This is a tactical, swing trade: buy on discipline at $63, stop at $55, target $85 over the next 45 trading days, but tighten risk if margins stall or FCF remains negative.
Palantir's blowout Q2 results and upgraded full-year outlook complete the rebound I forecast earlier this year. Revenue growth (93% y/y) and U.S. commercial revenue up 149% have shifted the risk/reward: fundamentals now justify a tactical upgrade. This trade idea lays out an entry at $172.08, stop at $156.00 and a target of $220.00 over a 180 tradi…
TFS Financial (TFSL) looks set to benefit from steady loan growth, a hefty cash dividend and improving investor sentiment in regional banks. Valuation is reasonable on a price-to-book around 2.6 and the stock sits below its 52-week high, giving room for a mid-term rebound. I outline a precise entry, stop and target for a 45-trading-day swing trade …
AII trades at a low multiple relative to fundamentals: market cap ~$495M, EV/EBITDA ~3.13, free cash flow ~$70.7M and EPS north of $4. With no debt and above-average return on equity, the stock looks set to re-rate if underwriting momentum and policy growth continue. This is a mid-term trade idea designed to capture a re-appraisal of the business w…
Cameco (CCJ) is a core uranium supplier that also owns a major equity interest in Westinghouse. Recent weakness after an earnings miss masks an attractive asymmetric trade: Westinghouse IPO timing has compressed, and an IPO could meaningfully re-rate Cameco’s valuation. We upgrade to a tactical long with a mid-term horizon and a defined entry, stop…
TKO Group (TKO) combines two global sports-entertainment franchises, WWE and UFC. Strong free cash flow, recent dividend increases, buybacks and insider purchases support a bullish trade. Technical momentum and manageable float make a mid-term long trade attractive, with defined entry, stop and target.
Diana Shipping (DSX) looks like a pragmatic long here after a recent rating upgrade. The stock trades like a low-growth, low-return shipping play while the underlying shipping market and fleet economics have a chance to re-rate DSX closer to peers such as GNK. This trade targets a re-rating over the next 45 trading days with tight risk control.
Skeena Resources (SKE) is transitioning from developer to producer at the Eskay Creek gold-silver project. With permits in hand, construction financing completed via a US$750m senior secured notes issuance, and the project ~49% complete, the stock looks positioned to re-rate as production risk recedes. The trade below targets a move toward the 52-w…
OPKO (OPK) trades like a beaten-down biotech but carries a diagnostics franchise and a balance sheet that make a measured long position attractive. With a market cap near $1.02B, EV/sales ~1.8x, improving technicals and upcoming program milestones with Entera Bio, I prefer a long trade sized modestly for recovery upside while protecting against con…
STMicroelectronics (STM) has given back a large chunk of recent gains and is trading near $52.22 after a corrective stretch. The company still benefits from structural growth in automotive microcontrollers, power electronics for EVs, and sensors. With a market cap near $47.4B, positive free cash flow, and improving technical momentum, a disciplined…
Edgewise Therapeutics has moved from a pure binary biotech to a company with optionality: an announced licensing arrangement with Servier should provide non-dilutive capital that extends runway for EDG-7500 and sevasemten. The trade: go long around current levels to capture upside into upcoming pivotal catalysts while protecting against trial and r…
